发明名称 2-methylene-19-nor-(20R)-1alpha-hydroxy-bishomopregnacalciferol
摘要 <p>Disclosed is a vitamin D analogue having the formula I wherein X1 and X2 are independently selected from H and hydroxy protecting groups. Also disclosed is the use of the above compound in the preparation of a medicament for the treatment of a biological condition selected from psoriasis; leukaemia; colon cancer; breast cancer; prostate cancer; multiple sclerosis; lupus; diabetes mellitus; host versus graft reaction; rejection of organ transplants; an inflammatory disease selected from rheumatoid arthritis; asthma, or inflammatory bowel diseases; a skin condition selected from wrinkles, lack of adequate skin firmness, lack of adequate dermal hydration, or insufficient sebum secretion; renal osteodystrophy; or osteoporosis.</p>
申请公布号 NZ555562(A) 申请公布日期 2009.02.28
申请号 NZ20050555562 申请日期 2005.11.18
申请人 WISCONSIN ALUMNI RESEARCH FOUNDATION 发明人 DELUCA, HECTOR F;PLUM, LORI A;CLAGETT-DAME, MARGARET
分类号 (IPC1-7):C07C401/00 主分类号 (IPC1-7):C07C401/00
代理机构 代理人
主权项
地址